Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Jul 15, 2023; 15(7): 1149-1173
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1149
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1149
Ligands/biomolecules | Cell lines | Targeting gene/G-quadruplex | Effects on G-quadruplex | Effects on genes | Anticancer phenotypes | Ref. |
BRACO-19 | HCT116, Flavopiridol-resistant HCT116 | Telomere | Stabilized G-quadruplex | Not detected | Rapid inhibition of cell growth | [173] |
RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) and RHPS4-derivatives | HT29, HCT116 | Telomere | Bound with G-quadruplex | Induced DNA damage | Stabilized TOPO1, cytotoxicity, inhibited cell proliferation, had synergistic anticancer effects with TOPO1 inhibitors | [174-177] |
A series of anthracene derivatives substituted with one or two 4,5-dihydro-1H-imidazol-2-yl-hydrazonic groups | LoVo | Telomere | Induced G-quadruplex structures, bound and stabilized G-quadruplex | Induced DNA damage | Cytotoxicity, telomerase inhibition | [178] |
EMICORON | HT29, HCT116, A90 colon epithelial tumor cell line | Telomere | Bound with G-quadruplex | Increased telomere damage | Cytotoxicity, inhibited cell proliferation and tumor growth of patient-derived tumor xenograft | [179,180] |
Chromene derivatives | HT29 | Telomere RNA | Bound with G-quadruplex | Not detected | Cytotoxicity | [181] |
TMPyP4 | SW480, SW620 | c-MYC | Stabilized the mutated G-quadruplex structure | Inhibited c-MYC expression | Silenced c-MYC expression | [182] |
CX-3543 (quarfloxin) | HT29 | c-MYC | Not detected | Inhibited c-MYC expression | Reduced CCAT1 expression, promoted cell apoptosis, inhibited cell proliferation and tumor growth of HT29 xenografts | [183] |
CX-5461 (pidnarulex) | HT-29, DLD-1, CT26 | Telomere, c-MYC, c-kit | Bound with G-quadruplex | Caused DNA damage | Inhibited tumor growth of CT26 xenografts | [184] |
Dihydrochelerythrine and its derivatives | HCT116 | c-MYC, c-kit | Stabilized G-quadruplex | Not detected | Inhibited cell proliferation | [185] |
Unsymmetrical bisacridines derivatives | HCT116 | c-MYC, KRAS | Bound and stabilized G-quadruplex | Not detected | Induced cytotoxicity, apoptosis and senescence | [144,186] |
7-carboxylate indolo[3,2-b] quinoline tri-alkylamine derivatives | HCT116, SW620 | KRAS, HSP90A | Stabilized G-quadruplex | Decreased KRAS and HSP90 mRNA expression, and KRAS transcription | Inhibited cell proliferation and protein expression of KRAS and HSP90A, promoted apoptosis | [187] |
3-[2-(Diethylamino)ethyl]-12-methyl-6-oxo-2,3,6,12-tetrahydro-1H-benzo[4,5]imidazo[1,2- a]imidazo[1’,2’:1,6]pyrido[2,3-d]pyrimidin-14-ium bromide | HCT116 | KRAS | Bound and stabilized G-quadruplex | Decreased KRAS mRNA expression | Inhibited cell proliferation | [188] |
Naphthalene diimides compound T5 | Colorectal cancer cell | rDNA | Had high affinity with G-quadruplex | Impaired RNA Pol I elongation, inhibited Pol I transcription | Inhibited cell growth by inducing a rapid inhibition of Pol I transcription, nucleolus disruption, proteasome-dependent Pol I catalytic subunit A degradation and autophagy | [189] |
Thiosugar naphthalene diimide conjugates | HT29 | Telomere, c-MYC, KRAS | Bound and stabilized G-quadruplex | Not detected | Cytotoxicity | [190] |
Gallic acid | SW480 SW620 | rDNA, c-MYC | Bound and stabilized G-quadruplex | Inhibited expression of rDNA and c-MYC | Cytotoxicity, inhibited tumor growth of SW480 xenografts | [191] |
HnRNPA1 | HCT116 | TRA2B promoter | Destabilized G-quadruplex | Stimulated TRA2B transcription | Promoted cell proliferation and expression of TRA2B | [192] |
SNRPA | HCT116 | BAG-1 mRNA | Bound with G-quadruplex | Inhibited translation of BAG-1 | Inhibited cell proliferation | [193,194] |
PPRHs | SW480 | c-MYC | Bound and stabilized G-quadruplex | Inhibited transcription of c-MYC | Inhibited cell proliferation | [159] |
- Citation: Han ZQ, Wen LN. Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects. World J Gastrointest Oncol 2023; 15(7): 1149-1173
- URL: https://www.wjgnet.com/1948-5204/full/v15/i7/1149.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i7.1149